AUTOIMMUNITY
20.9K views | +18 today
AUTOIMMUNITY
Pathology, Diagnosis and Therapies
Your new post is loading...
Your new post is loading...
Scooped by Gilbert C FAURE
January 24, 2023 4:18 AM
Scoop.it!

Neutrophil extracellular traps in systemic autoimmune and autoinflammatory diseases | Nature Reviews Immunology

Neutrophil extracellular traps in systemic autoimmune and autoinflammatory diseases | Nature Reviews Immunology | AUTOIMMUNITY | Scoop.it
Systemic autoimmune diseases are characterized by the failure of the immune system to differentiate self from non-self. These conditions are associated with significant morbidity and mortality, and they can affect many organs and systems, having significant clinical heterogeneity. Recent discoveries have highlighted that neutrophils, and in particular the neutrophil extracellular traps that they can release upon activation, can have central roles in the initiation and perpetuation of systemic autoimmune disorders and orchestrate complex inflammatory responses that lead to organ damage. Dysregulation of neutrophil cell death can lead to the modification of autoantigens and their presentation to the adaptive immune system. Furthermore, subsets of neutrophils that seem to be more prevalent in patients with systemic autoimmune disorders can promote vascular damage and increased oxidative stress. With the emergence of new technologies allowing for improved assessments of neutrophils, the complexity of neutrophil biology and its dysregulation is now starting to be understood. In this Review, we provide an overview of the roles of neutrophils in systemic autoimmune and autoinflammatory diseases and address putative therapeutic targets that may be explored based on this new knowledge. Neutrophils have a central role in the pathogenesis of systemic autoimmune and autoinflammatory diseases, particularly through neutrophil extracellular trap formation. Recent research suggests novel therapeutics targeting these structures that can improve patient outcomes.
No comment yet.
Scooped by Gilbert C FAURE
January 20, 2023 4:05 AM
Scoop.it!

https://www.sciencedirect.com/science/article/pii/S1297319X23000027?dgcid=author

Gilbert C FAURE's insight:

free access

No comment yet.
Scooped by Gilbert C FAURE
January 8, 2023 5:48 AM
Scoop.it!

Association of anti-Ro seropositivity with cardiac rhythm and conduction disturbances

Association of anti-Ro seropositivity with cardiac rhythm and conduction disturbances | AUTOIMMUNITY | Scoop.it
Anti-Ro seropositivity is positively associated with adult cardiac conduction disturbances and, to a lesser extent, cardiac rhythm disturbances, regardless of the presence of concurrent autoimmune disease.
No comment yet.
Scooped by Gilbert C FAURE
January 7, 2023 2:33 AM
Scoop.it!

Frontiers | Editorial: Heterogeneity of clinical phenotypes in type 1 diabetes and of beta cell deterioration in type 1 diabetes

pathophysiological components. Information garnered through many large multicenter cohort studies, multi-integration of bio-information obtained using genomics, epigenomics, proteomics and metabolomics approaches, and the utilization of datadriven classification strategies have drastically altered...
No comment yet.
Scooped by Gilbert C FAURE
December 31, 2022 7:05 AM
Scoop.it!

Auto-antibodies against type I IFNs in > 10% of critically ill COVID-19 patients: a prospective multicentre study | Annals of Intensive Care | Full Text

Auto-antibodies against type I IFNs in > 10% of critically ill COVID-19 patients: a prospective multicentre study | Annals of Intensive Care | Full Text | AUTOIMMUNITY | Scoop.it
Background Auto-antibodies (auto-Abs) neutralizing type I interferons (IFN) have been found in about 15% of critical cases COVID-19 pneumonia and less than 1% of mild or asymptomatic cases. Determining whether auto-Abs influence presentation and outcome of critically ill COVID-19 patients could lead to specific therapeutic interventions. Our objectives were to compare the severity at admission and the mortality of patients hospitalized for critical COVID-19 in ICU with versus without auto-Abs. Results We conducted a prospective multicentre cohort study including patients admitted in 11 intensive care units (ICUs) from Great Paris area hospitals with proven SARS-CoV-2 infection and acute respiratory failure. 925 critically ill COVID-19 patients were included. Auto-Abs neutralizing type I IFN-α2, β and/or ω were found in 96 patients (10.3%). Demographics and comorbidities did not differ between patients with versus without auto-Abs. At ICU admission, Auto-Abs positive patients required a higher FiO2 (100% (70–100) vs. 90% (60–100), p = 0.01), but were not different in other characteristics. Mortality at day 28 was not different between patients with and without auto-Abs (18.7 vs. 23.7%, p = 0.279). In multivariable analysis, 28-day mortality was associated with age (adjusted odds ratio (aOR) = 1.06 [1.04–1.08], p < 0.001), SOFA score (aOR = 1.18 [1.12–1.23], p < 0.001) and immunosuppression (aOR = 1.82 [1.1–3.0], p = 0.02), but not with the presence of auto-Abs (aOR = 0.69 [0.38–1.26], p = 0.23). Conclusions In ICU patients, auto-Abs against type I IFNs were found in at least 10% of patients with critical COVID-19 pneumonia. They were not associated with day 28 mortality.
No comment yet.
Scooped by Gilbert C FAURE
December 17, 2022 1:58 AM
Scoop.it!

Multi-omic interactions in the gut of children at the onset of islet autoimmunity | Microbiome | Full Text

Multi-omic interactions in the gut of children at the onset of islet autoimmunity | Microbiome | Full Text | AUTOIMMUNITY | Scoop.it
Background The gastrointestinal ecosystem is a highly complex environment with a profound influence on human health. Inflammation in the gut, linked to an altered gut microbiome, has been associated with the development of multiple human conditions including type 1 diabetes (T1D).
No comment yet.
Scooped by Gilbert C FAURE
December 11, 2022 4:09 AM
Scoop.it!

What Is the Most Common Autoimmune Disease?

What Is the Most Common Autoimmune Disease? | AUTOIMMUNITY | Scoop.it
I recently got a diabetes diagnosis, and it was a surprise to me that diabetes type I is classified as an autoimmune disorder. I know diabetes is an epidemic in the U.S., but how common is it? What is the most common autoimmune disease?
No comment yet.
Scooped by Gilbert C FAURE
November 15, 2022 4:58 AM
Scoop.it!

Can SARS-CoV-2 trigger new onset of autoimmune disease in adults? A case-based review

Can SARS-CoV-2 trigger new onset of autoimmune disease in adults? A case-based review | AUTOIMMUNITY | Scoop.it
ARS-CoV-2; COVID-19; New onset; Autoimmune disease; Adults.
No comment yet.
Scooped by Gilbert C FAURE
October 28, 2022 1:37 PM
Scoop.it!

JCI - Type 1 diabetes: what is the role of autoimmunity in β cell death?

JCI - Type 1 diabetes: what is the role of autoimmunity in β cell death? | AUTOIMMUNITY | Scoop.it
The study by Warncke et al. (13) raises several questions about the pathogenesis of type 1 diabetes. First, what is the true role of autoimmunity, an important precipitating factor or a mere epiphenomenon?
No comment yet.
Scooped by Gilbert C FAURE
October 15, 2022 11:06 AM
Scoop.it!

Neutrophils in ANCA-associated vasculitis: Mechanisms and implications for management | Read by QxMD

Neutrophils in ANCA-associated vasculitis: Mechanisms and implications for management | Read by QxMD | AUTOIMMUNITY | Scoop.it
Create a free QxMD account to receive personalized paper recommendations, relevant to your practice. Get Started JOURNAL ARTICLE REVIEW Neutrophils in ANCA-associated vasculitis: Mechanisms and implications for management Shangqing Ge, Xingyu Zhu, Qinyao Xu, Junyan Wang, Cheng An, Ying Hu, Fan Yang, Xinyi Wang, Yipin Yang, Shuwen Chen, Ruimin Jin, Haiyan Li, Xinchen Peng, Yue Liu, Junnan Xu, Minhui Zhu, Zongwen Shuai Frontiers in Pharmacology 2022, 13: 957660 Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a group of systemic autoimmune diseases, which is typified by inflammatory necrosis predominantly affecting the small vessels and often accompanied by positive ANCA. Clinically, AAV primarily includes microscopic polyangiitis (MPA), granulomatosis with polyangiitis (GPA), and eosinophilic granulomatosis with polyangiitis (EGPA). It has been found that in AAV pathogenesis, both innate and adaptive immunity are related to neutrophil function mutually. Many proteins, such as myeloperoxidase (MPO) and proteinase 3 (PR3), in neutrophil cytoplasm lead to the production of proteins such as MPO-ANCA and PR3-ANCA by activating adaptive immunity. In addition, through the process of neutrophil extracellular trap (NET) formation, activation of an alternative complement pathway and the respiratory burst can stimulate the neutrophils close to vascular endothelial cells and will participate the vessel inflammation. This review aims to reveal the potential mechanisms regulating the association between the neutrophils and various types of AAVs and to emphasize the results of recent findings on these interactions. Moreover, multiple underlying signaling pathways involved in the regulation of neutrophils during AAV processes have also been discussed. The ultimate goal of this review is to identify novel biomarkers and therapeutic targets for AAV management in the future. Full Text Links We have located open access full text paper links. Full Text PDF Full Text Web Additional links Discussion You are not logged in. Sign Up or Log In to join the discussion. Related Papers Clinical characteristics, the diagnostic criteria and management recommendation of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) proposed by Japan Otological Society. Yasuaki Harabuchi, Kan Kishibe, Kaori Tateyama, Yuka Morita, Naohiro Yoshida, Masahiro Okada, Yasuomi Kunimoto, Takeshi Watanabe, Akira Inagaki, Tadao Yoshida, Mitsuyoshi Imaizumi, Takeshi Nakamura, Takeshi Matsunobu, Shigeto Kobayashi, Yukiko Iino, Shingo Murakami, Haruo Takahashi, Tetsuya Tono Auris, Nasus, Larynx 2021, 48 (1): 2-14 Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management. Giorgio Trivioli, Ana Marquez, Davide Martorana, Michelangelo Tesi, Andreas Kronbichler, Paul A Lyons, Augusto Vaglio Nature Reviews. Rheumatology 2022, 18 (10): 559-574 Myeloperoxidase-ANCA-positive granulomatosis with polyangiitis is a distinct subset of ANCA-associated vasculitis: A retrospective analysis of 455 patients from a single center in China. Dong-Yuan Chang, Zhi-Ying Li, Min Chen, Ming-Hui Zhao Seminars in Arthritis and Rheumatism 2019, 48 (4): 701-706 Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Alvise Berti, Roscoe Warner, Kent Johnson, Divi Cornec, Darrell Schroeder, Brian Kabat, Carol A Langford, Gary S Hoffman, Fernanado C Fervenza, Cees G M Kallenberg, Philip Seo, Robert Spiera, E William St Clair, Paul Brunetta, John H Stone, Peter A Merkel, Ulrich Specks, Paul A Monach Arthritis & Rheumatology 2018, 70 (7): 1114-1121 Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention. Cees G M Kallenberg, Coen A Stegeman, Wayel H Abdulahad, Peter Heeringa American Journal of Kidney Diseases 2013, 62 (6): 1176-87 ANCA associated vasculitis (AAV): a review for internists. Kinanah Yaseen, Brian F Mandell Postgraduate Medicine 2022 July 21, : 1-11 Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Toward an Individualized Approach. Javier Villacorta, Laura Martinez-Valenzuela, Irene Martin-Capon, Juliana Bordignon-Draibe Nephron 2021 December 15, : 1-17 Optimal management of ANCA-associated vasculitis before and during pregnancy: current perspectives. Ann-Christin Pecher, Melanie Henes, Joerg Christoph Henes Archives of Gynecology and Obstetrics 2022 September 14 Association of antineutrophil cytoplasmic antibody (ANCA) specificity with demographic and clinical characteristics of patients with ANCA‑associated vasculitides. Krzysztof Wójcik, Anna Masiak, Radosław Jeleniewicz, Katarzyna Jakuszko, Iwona Brzosko, Hanna Storoniak, Joanna Kur-Zalewska, Małgorzata Wisłowska, Marta Madej, Anna Hawrot-Kawecka, Piotr Głuszko, Eugeniusz J Kucharz On Behalf Of Polvas Consortium Polish Archives of Internal Medicine 2022 March 30, 132 (3) Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis. T V Beketova Terapevticheskiĭ Arkhiv 2018 May 11, 90 (5): 13-22 Make the most of Read. Download the mobile app.
No comment yet.
Scooped by Gilbert C FAURE
October 12, 2022 10:27 AM
Scoop.it!

Epigenetic regulation of B cells and its role in autoimmune pathogenesis | Cellular & Molecular Immunology

Epigenetic regulation of B cells and its role in autoimmune pathogenesis | Cellular & Molecular Immunology | AUTOIMMUNITY | Scoop.it
B cells play a pivotal role in the pathogenesis of autoimmune diseases. Although previous studies have shown many genetic polymorphisms associated with B-cell activation in patients with various autoimmune disorders, progress in epigenetic research has revealed new mechanisms leading to B-cell...
No comment yet.
Scooped by Gilbert C FAURE
January 20, 2023 10:18 AM
Scoop.it!

Overview of autoimmune liver disease: Prevalence, risk facto... : Clinical Liver Disease

Overview of autoimmune liver disease: Prevalence, risk facto... : Clinical Liver Disease | AUTOIMMUNITY | Scoop.it
An abstract is unavailable.
No comment yet.
Scooped by Gilbert C FAURE
January 17, 2023 4:22 AM
Scoop.it!

immunopathology of diabetes for students by CEI

No comment yet.
Scooped by Gilbert C FAURE
January 7, 2023 12:57 PM
Scoop.it!

https://www.sciencedirect.com/science/article/abs/pii/S1297319X23000027?via%3Dihub

No comment yet.
Scooped by Gilbert C FAURE
January 1, 2023 4:53 AM
Scoop.it!

Autoimmune regulation of chronic pain : PAIN Reports

Autoimmune regulation of chronic pain : PAIN Reports | AUTOIMMUNITY | Scoop.it
Chronic pain is an unpleasant and debilitating condition that is often poorly managed by existing th...
No comment yet.
Scooped by Gilbert C FAURE
December 30, 2022 9:47 AM
Scoop.it!

https://onlinelibrary.wiley.com/doi/10.1111/jth.15585

No comment yet.
Scooped by Gilbert C FAURE
December 17, 2022 1:57 AM
Scoop.it!

The role of the intestinal microbiome in antiphospholipid syndrome | Read by QxMD

The role of the intestinal microbiome in antiphospholipid syndrome | Read by QxMD | AUTOIMMUNITY | Scoop.it
Create a free QxMD account to receive personalized paper recommendations, relevant to your practice. Get Started The role of the intestinal microbiome in antiphospholipid syndrome Dagmar J M van Mourik, Dorien M Salet, Saskia Middeldorp, Max Nieuwdorp, Thijs E van Mens Frontiers in Immunology 2022, 13: 954764 The antiphospholipid syndrome (APS) is a thrombotic autoimmune disease in which the origin of the disease-characterizing autoantibodies is unknown. Increased research effort into the role of the intestinal microbiome in autoimmunity has produced new insights in this field. This scoping review focusses on the gut microbiome in its relation to APS. EMBASE and MEDLINE were searched for original studies with relevance to the relation between the gut microbiome and APS. Thirty studies were included. Work on systemic lupus erythematosus, which strongly overlaps with APS, has shown that patients often display an altered gut microbiome composition, that the disease is transferable with the microbiome, and that microbiome manipulation affects disease activity in murine lupus models. The latter has also been shown for APS, although data on microbiome composition is less consistent. APS patients do display an altered intestinal IgA response. Evidence has accrued for molecular mimicry as an explanatory mechanism for these observations in APS and other autoimmune diseases. Specific gut microbes express proteins with homology to immunodominant APS autoantigens. The disease phenotype appears to be dependent on these mimicking proteins in an APS mouse model, and human APS B- and T-cells indeed cross-react with these mimics. Pre-clinical evidence furthermore suggests that diet may influence autoimmunity through the microbiome, as may microbial short chain fatty acid production, though this has not been studied in APS. Lastly, the microbiome has been shown to affect key drivers of thrombosis, and may thus affect APS severity through non-immunological mechanisms. Overall, these observations demonstrate the impact of the intestinal microbiome on autoimmunity and the importance of understanding its role in APS. Full Text Links We have located open access full text paper links. Full Text PDF Full Text Web Additional links Discussion You are not logged in. Sign Up or Log In to join the discussion. Related Papers Diet, microbiota and autoimmune diseases. S M Vieira, O E Pagovich, M A Kriegel Lupus 2014, 23 (6): 518-26 Pathogenic Autoreactive T and B Cells Cross-React with Mimotopes Expressed by a Common Human Gut Commensal to Trigger Autoimmunity. William E Ruff, Carina Dehner, Woo J Kim, Odelya Pagovich, Cassyanne L Aguiar, Andrew T Yu, Alexander S Roth, Silvio Manfredo Vieira, Christina Kriegel, Olamide Adeniyi, Melissa J Mulla, Vikki M Abrahams, William W Kwok, Ruth Nussinov, Doruk Erkan, Andrew L Goodman, Martin A Kriegel Cell Host & Microbe 2019 July 10, 26 (1): 100-113.e8 Abstracts of Presentations at the Association of Clinical Scientists 143 rd Meeting Louisville, KY May 11-14,2022. (no author information available yet) Annals of Clinical and Laboratory Science 2022, 52 (3): 511-525 The role of the gut microbiota in the pathogenesis of antiphospholipid syndrome. William E Ruff, Silvio M Vieira, Martin A Kriegel Current Rheumatology Reports 2015, 17 (1): 472 [The role of the microbiome in lupus and antiphospholipid syndrome]. Sylvio Redanz, Martin A Kriegel Zeitschrift Für Rheumatologie 2022, 81 (5): 423-426 Identification of novel, clinically correlated autoantigens in the monogenic autoimmune syndrome APS1 by proteome-wide PhIP-Seq. Sara E Vazquez, Elise Mn Ferré, David W Scheel, Sara Sunshine, Brenda Miao, Caleigh Mandel-Brehm, Zoe Quandt, Alice Y Chan, Mickie Cheng, Michael German, Michail Lionakis, Joseph L DeRisi, Mark S Anderson ELife 2020 May 15, 9 B cells in primary antiphospholipid syndrome: Review and remaining challenges. Yannick Dieudonné, Aurélien Guffroy, Vincent Poindron, Pauline Soulas Sprauel, Thierry Martin, Anne-Sophie Korganow, Vincent Gies Autoimmunity Reviews 2021, 20 (5): 102798 Gut Microbiota in Lupus: a Butterfly Effect? Rongli Li, Xia Meng, Beidi Chen, Lidan Zhao, Xuan Zhang Current Rheumatology Reports 2021 April 16, 23 (4): 27 Gut microbiota differently contributes to intestinal immune phenotype and systemic autoimmune progression in female and male lupus-prone mice. Benjamin M Johnson, Marie-Claude Gaudreau, Radhika Gudi, Robert Brown, Gary Gilkeson, Chenthamarakshan Vasu Journal of Autoimmunity 2020, 108: 102420 Gut Microbiota, Leaky Gut, and Autoimmune Diseases. Anna Christovich, Xin M Luo Frontiers in Immunology 2022, 13: 946248 Make the most of Read. Download the mobile app.
Diedler Quentin's curator insight, December 28, 2025 4:44 AM
Le syndrome des antiphospholipides (SAPL) est une maladie auto-immune thrombotique dont l’origine des autoanticorps caractéristiques reste encore mal comprise. Une revue récente publiée dans Frontiers in Immunology (van Mourik et al., 2022) met en lumière un acteur de plus en plus étudié dans les maladies auto-immunes : le microbiote intestinal. Cette revue de la littérature analyse une trentaine d’études explorant le lien entre microbiote et SAPL, en s’appuyant également sur les connaissances issues du lupus érythémateux systémique (LES), une pathologie étroitement liée au SAPL. Dans le lupus, les patients présentent fréquemment une dysbiose intestinale, et les modèles animaux ont montré que la maladie pouvait être partiellement transférée via le microbiote. De plus, la manipulation du microbiote influence l’activité de la maladie, suggérant un rôle causal. Dans le SAPL, les données sont encore limitées mais plusieurs signaux convergent. Les patients présentent notamment une réponse IgA intestinale altérée, signe d’une interaction anormale entre le système immunitaire et les bactéries intestinales. L’un des mécanismes les plus convaincants mis en avant est celui du mimétisme moléculaire : certaines bactéries du microbiote expriment des protéines ressemblant fortement aux auto-antigènes majeurs du SAPL, comme la β2-glycoprotéine I. Ces similitudes peuvent induire une réponse immunitaire croisée, confirmée à la fois chez l’animal et chez l’humain, avec des lymphocytes B et T réactifs à ces protéines bactériennes. Au-delà de l’auto-immunité, le microbiote pourrait également influencer la thrombose, élément central du SAPL, via des effets sur l’activation plaquettaire, la fonction endothéliale et la coagulation. Par ailleurs, des données précliniques suggèrent que l’alimentation et les métabolites bactériens (comme les acides gras à chaîne courte) pourraient moduler l’auto-immunité, bien que ces aspects restent encore inexplorés spécifiquement dans le SAPL. 
En conclusion, cette revue souligne l’importance croissante du microbiote intestinal dans la compréhension du SAPL. Elle ouvre des perspectives prometteuses, tant pour l’identification de nouveaux mécanismes physiopathologiques que pour le développement futur de stratégies thérapeutiques innovantes, complémentaires aux traitements anticoagulants actuels.
Gilbert C FAURE's comment, December 28, 2025 5:13 AM
un seul post!!! des pistes sur https://www.scoop.it/topic/autoimmunity?q=antiphospholipid
Scooped by Gilbert C FAURE
December 11, 2022 4:06 AM
Scoop.it!

American College of Rheumatology Reading Room | Antinuclear Antibodies on the Rise in U.S. | MedPage Today

American College of Rheumatology Reading Room | Antinuclear Antibodies on the Rise in U.S. | MedPage Today | AUTOIMMUNITY | Scoop.it
The prevalence of antinuclear antibodies (ANA) -- the most common biomarker of autoimmunity -- has increased considerably in recent years, particularly among teenagers. Researchers measured ANA in 13,519 participants ≥12 years of age who participated in the National Health and Nutrition...
No comment yet.
Scooped by Gilbert C FAURE
November 18, 2022 5:10 AM
Scoop.it!

Immunotherapy-Related Myocarditis Linked to T Cells Targeting Cardiac-Specific Antigen

Immunotherapy-Related Myocarditis Linked to T Cells Targeting Cardiac-Specific Antigen | AUTOIMMUNITY | Scoop.it
Researchers say identification of α-myosin as an autoantigen may help to identify immunotherapy-treated cancer patients who are at higher risk for myocarditis.
No comment yet.
Scooped by Gilbert C FAURE
November 10, 2022 4:12 AM
Scoop.it!

Pathogenesis of Lupus by Laurent Arnaud, with new treatment targets...

No comment yet.
Scooped by Gilbert C FAURE
October 15, 2022 11:06 AM
Scoop.it!

A cell-based assay for detection of anti-fibrillarin autoantibodies with performance equivalent to immunoprecipitation

A cell-based assay for detection of anti-fibrillarin autoantibodies with performance equivalent to immunoprecipitation | AUTOIMMUNITY | Scoop.it
Anti-fibrillarin autoantibodies are useful for the diagnosis and prognosis of systemic sclerosis (SSc). Anti-fibrillarin produces a clumpy nucleolar pattern in indirect immunofluorescence assay on HEp-2 cells (HEp-2 IFA).
No comment yet.
Scooped by Gilbert C FAURE
October 15, 2022 11:04 AM
Scoop.it!

Research news - Pancreatic image bank expected to help advance diabetes research worldwide - University of Exeter

Research news - Pancreatic image bank expected to help advance diabetes research worldwide - University of Exeter | AUTOIMMUNITY | Scoop.it
No comment yet.